Gary Marcus 评联合国安理会 AI 简报会：共识与一处夸大
Historic UN Security Council Briefing on AI
在联合国安理会 AI 简报会上，Yoshua Bengio、Sam Altman、Dario Amodei 和 Hugging Face CEO Clement Delangue 先后发言，Gary Marcus 称几乎认同四人所说内容，各方在飞行前安全测试、透明度审计、责任追究、全球对话与立即行动上形成共识。他认为唯一明显的杂音来自 Altman 和 Amodei 演讲中的自我夸耀，尤其 Amodei 将当天公布的一项酶相关发现过早类比为 CRISPR，Angela Rasmussen 指出该研究只找到序列、可能表达了蛋白，尚未做有意义的功能表征。
正文
当前显示原文，中文全文译文尚未就绪。
We all agree on what needs to be done. Now let’s do it.
This afternoon at the UN Security Council, Yoshua Bengio, Sam Altman, Dario Amodei, and Hugging Face CEO and Cofounder Clement Delangue gave back-to-back speeches.
I absolutely loved Bengio’s, agreeing with virtually every well-crafted word, and, with his permission, am reprinting his remarks in full, below.
The more surprising thing is that I agreed with almost all of what the other three said as well (and most of what followed, as many other speakers from around the world gave their own remarks).1
Pretty much everyone converged on exactly the same things I keep harping on:
The need for preflight safety testing; The need for transparency auditing; The need for liability; The need for global dialogue and international cooperation; The need for immediate action
At this point, with leading scientists (like Bengio) and major CEOs all reaching consensus, there is no excuse not to start implementing them.
Here are Yoshua Bengio’s beautiful and important remarks. Humanity will regret it if we do not take heed.
The full session (which starts several minutes into the recording) can be viewed here. A transcript will be available at the same location.
The only real false note came from some self-congratulatory hype in the speeches of Altman and Amodei, especially Amodei’s. Amodei in particular overhyped a discovery announced early today, in enzymes, which Amodei prematurely tried to liken to the truly revolutionary gene editing system CRISPR. In reality, as Dr. Angela Rasmussen, put it “They found the sequence, probably expressed a protein, but haven’t done any meaningful functional characterization… It’s not bad, it’s just very premature to compare to CRISPR.”